These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 18618590)

  • 21. Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome in children and adolescents.
    Lowe EJ; Werner EJ
    Semin Thromb Hemost; 2005 Dec; 31(6):717-30. PubMed ID: 16388423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Children and adults with thrombotic thrombocytopenic purpura associated with severe, acquired Adamts13 deficiency: comparison of incidence, demographic and clinical features.
    Reese JA; Muthurajah DS; Kremer Hovinga JA; Vesely SK; Terrell DR; George JN
    Pediatr Blood Cancer; 2013 Oct; 60(10):1676-82. PubMed ID: 23729372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pulmonary involvement in patients with thrombotic thrombocytopenic purpura.
    Nokes T; George JN; Vesely SK; Awab A
    Eur J Haematol; 2014 Feb; 92(2):156-63. PubMed ID: 24164539
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreasing frequency of plasma exchange complications in patients treated for thrombotic thrombocytopenic purpura-hemolytic uremic syndrome, 1996 to 2011.
    Som S; Deford CC; Kaiser ML; Terrell DR; Kremer Hovinga JA; Lämmle B; George JN; Vesely SK
    Transfusion; 2012 Dec; 52(12):2525-32; quiz 2524. PubMed ID: 22501034
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The incidence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS-13 deficiency.
    Terrell DR; Williams LA; Vesely SK; Lämmle B; Hovinga JA; George JN
    J Thromb Haemost; 2005 Jul; 3(7):1432-6. PubMed ID: 15978100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survival and relapse in patients with thrombotic thrombocytopenic purpura.
    Kremer Hovinga JA; Vesely SK; Terrell DR; Lämmle B; George JN
    Blood; 2010 Feb; 115(8):1500-11; quiz 1662. PubMed ID: 20032506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
    Furlan M; Robles R; Galbusera M; Remuzzi G; Kyrle PA; Brenner B; Krause M; Scharrer I; Aumann V; Mittler U; Solenthaler M; Lämmle B
    N Engl J Med; 1998 Nov; 339(22):1578-84. PubMed ID: 9828245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical experience in treatment of thrombotic thrombocytopenic purpura--hemolytic uremic syndrome with 28 patients.
    Vuclić D; Rajić Z; Savić N; Miković D; Budisin Z; Antonijević NM; Obradović S; Jevtić D; Bettoni G; Casoli G; Peyvandi F
    Acta Chir Iugosl; 2013; 60(1):29-38. PubMed ID: 24669560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thrombotic microangiopathy: current knowledge and outcomes with plasma exchange.
    Clark WF
    Semin Dial; 2012; 25(2):214-9. PubMed ID: 22309967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic relevance of ADAMTS13 activity: evaluation of 28 patients with thrombotic thrombocytopenic purpura - hemolytic uremic syndrome clinical diagnosis.
    Vucelić D; Miković D; Rajić Z; Savić N; Budisin Z; Antonijević NM; Obradović S; Jevtić D; Palla R; Valsecchio C; Peyvandi F
    Srp Arh Celok Lek; 2013; 141(7-8):466-74. PubMed ID: 24073552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: diagnosis and management.
    George JN; Gilcher RO; Smith JW; Chandler L; Duvall D; Ellis C
    J Clin Apher; 1998; 13(3):120-5. PubMed ID: 9828022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How I treat patients with thrombotic thrombocytopenic purpura: 2010.
    George JN
    Blood; 2010 Nov; 116(20):4060-9. PubMed ID: 20686117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [TTP/HUS and VWF/ADAMTS-13].
    Fujimura Y
    Rinsho Ketsueki; 2003 Dec; 44(12):1144-53. PubMed ID: 14978930
    [No Abstract]   [Full Text] [Related]  

  • 34. Thrombotic microangiopathies: thrombotic thrombocytopenic purpura / hemolytic uremic syndrome.
    Polito MG; Kirsztajn GM
    J Bras Nefrol; 2010; 32(3):303-15. PubMed ID: 21103695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deficient activity of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura.
    Furlan M
    Expert Rev Cardiovasc Ther; 2003 Jul; 1(2):243-55. PubMed ID: 15030284
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hemolytic uremic syndrome and thrombotic thrombocytopenic purpura].
    Masset C; Dubois B; Rorive G
    Rev Med Liege; 2002 Jan; 57(1):33-9. PubMed ID: 11899496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A support group for patients who have recovered from thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS): The six-year experience of the Oklahoma TTP-HUS Study Group.
    Howard MA; Duvall D; Terrell DR; Christopher AT; Thomas I; Holloway N; Vesely SK; George JN;
    J Clin Apher; 2003; 18(1):16-20. PubMed ID: 12717788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TTP/HUS and prognosis: the syndrome and the disease(s).
    Forzley BR; Clark WF
    Kidney Int Suppl; 2009 Feb; (112):S59-61. PubMed ID: 19180139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Different disparities of gender and race among the thrombotic thrombocytopenic purpura and hemolytic-uremic syndromes.
    Terrell DR; Vesely SK; Kremer Hovinga JA; Lämmle B; George JN
    Am J Hematol; 2010 Nov; 85(11):844-7. PubMed ID: 20799358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular mechanisms in thrombotic thrombocytopenic purpura.
    Tsai HM
    Semin Thromb Hemost; 2004 Oct; 30(5):549-57. PubMed ID: 15497097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.